V07.5: Use of agents affecting estrogen receptors and estrogen levels
Code first, if applicable:
malignant neoplasm of breast (174.0-174.9, 175.0-175.9)
malignant neoplasm of prostate (185)
Use additional code, if applicable, to identify:
estrogen receptor positive status (V86.0)
family history of breast cancer (V16.3)
genetic susceptibility to cancer (V84.01-V84.09)
personal history of breast cancer (V10.3)
personal history of prostate cancer (V10.46)
postmenopausal status (V49.81)
Excludes:
hormone replacement therapy (postmenopausal) (V07.4)